LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Interactive effects of protonated nicotine concentration and device power on ENDS nicotine delivery, puff topography, and subjective effects.

    Eversole, Alisha / Budd, Serenity / Karaoghlanian, Nareg / Lipato, Thokozeni / Eissenberg, Thomas / Breland, Alison B

    Experimental and clinical psychopharmacology

    2022  Volume 31, Issue 2, Page(s) 443–454

    Abstract: Electronic nicotine delivery systems (ENDSs) produce an aerosol by heating a liquid that often contains nicotine. The nicotine can be protonated that may make the aerosol easier to inhale than freebase nicotine. This study's purpose is to determine, in ... ...

    Abstract Electronic nicotine delivery systems (ENDSs) produce an aerosol by heating a liquid that often contains nicotine. The nicotine can be protonated that may make the aerosol easier to inhale than freebase nicotine. This study's purpose is to determine, in cigarette smokers and ENDS users, the effects of three concentrations of protonated nicotine aerosolized at two different power settings. Forty-five participants (22 cigarette smokers and 23 ENDS users) completed some or all of six sessions that varied by liquid nicotine concentration (10, 15, or 30 mg/ml protonated nicotine) and device power (15 or 30 W). Participants took 10 puffs from each product and then used each product for 90 min
    MeSH term(s) Humans ; Nicotine ; Smoking ; Smokers ; Electronic Nicotine Delivery Systems ; Tobacco Products
    Chemical Substances Nicotine (6M3C89ZY6R)
    Language English
    Publishing date 2022-06-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1209960-0
    ISSN 1936-2293 ; 1064-1297
    ISSN (online) 1936-2293
    ISSN 1064-1297
    DOI 10.1037/pha0000576
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The baseline risk of multiple febrile seizures in the same febrile illness: a meta-analysis.

    Henry, Christopher / Cockburn, Chelsea / Simpson, Mary Helen / Budd, Serenity / Wang, Chen / Dinov, Darina

    European journal of pediatrics

    2022  Volume 181, Issue 6, Page(s) 2201–2213

    Abstract: The baseline risk for multiple febrile seizures within the same febrile illness is largely unknown. Estimates range from 5 to 30%. Imprecise estimates can lead to incorrectly powering studies investigating the management of febrile seizures. To estimate ... ...

    Abstract The baseline risk for multiple febrile seizures within the same febrile illness is largely unknown. Estimates range from 5 to 30%. Imprecise estimates can lead to incorrectly powering studies investigating the management of febrile seizures. To estimate the risk of multiple febrile seizures in the same febrile illness, we systematically reviewed and conducted a meta-analysis of studies from January 2000 to December 2021 that contained data for the number of children for both simple and complex febrile seizures in the same febrile illness. We searched MEDLINE, EMBASE, and Web of Science for randomized, quasi-randomized, prospective, and retrospective trials that involved children with febrile seizures. A total of 23,131 febrile illnesses with febrile seizures met the inclusion criteria. The estimated baseline risk of multiple febrile seizures in the same febrile illness was 17% (95% CI, 16-19%). However, the 30 cohorts that included both admitted and non-admitted patients had a lower percentage of multiple FSs within the same illness (14%; 95% CI, 12-15%) than the 30 cohorts that enrolled only admitted patients (20%; 95% CI, 16-25%).
    Conclusion: Researchers can use estimates in this paper to design future studies. Taking into the account the substantial heterogeneity between countries and studies, clinicians could cautiously use our estimates in their clinical assessment and be better able to set parental expectations about a child's chances of having another febrile seizure during the current illness.
    Trial registration: PROSPERO CRD42020191784. Registered July 18, 2020.
    What is known: • There is renewed interest in the diagnostic workup and prophylactic treatment of febrile seizures to prevent repeat seizures in the same febrile illness. • There is a lack of accurate estimates of the baseline risk for multiple febrile seizures in the same illness to properly design studies investigating management.
    What is new: • This study provides the most robust estimates for the baseline risk for multiple febrile seizures in the same illness.
    MeSH term(s) Child ; Hospitalization ; Humans ; Prospective Studies ; Retrospective Studies ; Seizures, Febrile/diagnosis ; Seizures, Febrile/epidemiology ; Seizures, Febrile/etiology
    Language English
    Publishing date 2022-03-16
    Publishing country Germany
    Document type Journal Article ; Meta-Analysis
    ZDB-ID 194196-3
    ISSN 1432-1076 ; 0340-6199 ; 0943-9676
    ISSN (online) 1432-1076
    ISSN 0340-6199 ; 0943-9676
    DOI 10.1007/s00431-022-04431-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Quality of life and safety impact of COVID-19 associated smell and taste disturbances.

    Coelho, Daniel H / Reiter, Evan R / Budd, Serenity G / Shin, Yongyun / Kons, Zachary A / Costanzo, Richard M

    American journal of otolaryngology

    2021  Volume 42, Issue 4, Page(s) 103001

    Abstract: Objective: The association between COVID-19 and chemosensory loss has garnered substantial attention, however to date little is known about the real-life consequences of impairment in this unique patient population. The aim of this study is to evaluate ... ...

    Abstract Objective: The association between COVID-19 and chemosensory loss has garnered substantial attention, however to date little is known about the real-life consequences of impairment in this unique patient population. The aim of this study is to evaluate the quality of life (QOL) and personal safety deficits experienced by patients with COVID-19 infection.
    Study design: Prospective, longitudinal questionnaires.
    Setting: National survey.
    Methods: A longitudinal web-based nationwide survey of adults with COVID-19 and/or a sudden change in smell and taste was launched April 10, 2020. Previously published questions on chemosensory-related QOL and safety events were asked at the 6-month follow-up survey.
    Results: As of February 10, 2021, 480 eligible respondents took the 6-month questionnaire, of whom 322 were COVID-19 positive. Impact on QOL was substantial with 96% of subjects reporting at least one of the defined deficits, and over 75% reporting at least 3 of these. "Reduced enjoyment of food" was the most common complaint (87%), while 43% of subjects self-reported depression. The prevalence of safety-related issues was common in this population, with over 57% reporting at least one, and 36% reporting 2 or more events. Of the events asked, the inability to smell smoke that others could perceive was the most common at 45%.
    Conclusions: COVID-19 associated chemosensory losses have a real and substantial impact on both quality of life and safety, beyond mere inconvenience. The high prevalence of these issues despite a relatively short period of olfactory deficit should alert clinicians to the serious risks to an already vulnerable patient population.
    MeSH term(s) Adolescent ; Adult ; Aged ; COVID-19/complications ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Olfaction Disorders/complications ; Olfaction Disorders/psychology ; Olfaction Disorders/virology ; Prospective Studies ; Quality of Life ; Risk ; Surveys and Questionnaires ; Taste Disorders/complications ; Taste Disorders/psychology ; Taste Disorders/virology ; Young Adult
    Language English
    Publishing date 2021-03-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604541-8
    ISSN 1532-818X ; 0196-0709
    ISSN (online) 1532-818X
    ISSN 0196-0709
    DOI 10.1016/j.amjoto.2021.103001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Predictors of smell recovery in a nationwide prospective cohort of patients with COVID-19.

    Coelho, Daniel H / Reiter, Evan R / Budd, Serenity G / Shin, Yongyun / Kons, Zachary A / Costanzo, Richard M

    American journal of otolaryngology

    2021  Volume 43, Issue 1, Page(s) 103239

    Abstract: Objective: To determine which factors (demographic, symptoms, comorbidities, and treatments) are associated with recovery of smell in patients with COVID-19 associated olfactory loss.: Study design: Prospective, longitudinal questionnaires.: ... ...

    Abstract Objective: To determine which factors (demographic, symptoms, comorbidities, and treatments) are associated with recovery of smell in patients with COVID-19 associated olfactory loss.
    Study design: Prospective, longitudinal questionnaires.
    Setting: National survey.
    Methods: A longitudinal web-based nationwide survey of adults with COVID-19 associated smell and taste loss was launched April 10, 2020. After completing an initial entry survey, participants received detailed follow-up questionnaires 14 days, and 1, 3 and 6 months later.
    Results: As of June 25, 2021, 798 participants met study inclusion criteria and completed 6-month questionnaires. Of demographic characteristics only age <40 years was positively associated with smell recovery (p < .003). Of symptoms, difficulty breathing was negatively associated with smell recovery (p < .004), and nasal congestion positively associated with smell recovery (p < .03). Of pre-existing comorbidities only previous head injury (p < .017) was negatively associated with smell recovery. None of the queried medications used to treat COVID were associated with better rates of smell recovery.
    Conclusions: Age <40 and presence of nasal congestion at time of COVID-19 infection were predictive of improved rates of smell recovery, while difficulty breathing at time of COVID-19 infection, and prior head trauma predicted worsened rates of recovery. Further study will be required to identify potential mechanisms for the other observed associations. Such information can be used by clinicians to counsel patients suffering COVID-19 associated smell loss as to prognosis for recovery.
    MeSH term(s) Adult ; COVID-19/complications ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Olfaction Disorders/physiopathology ; Olfaction Disorders/virology ; Predictive Value of Tests ; Prospective Studies ; Recovery of Function ; SARS-CoV-2 ; Surveys and Questionnaires
    Language English
    Publishing date 2021-09-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604541-8
    ISSN 1532-818X ; 0196-0709
    ISSN (online) 1532-818X
    ISSN 0196-0709
    DOI 10.1016/j.amjoto.2021.103239
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top